Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2024

Open Access 01-12-2024 | Amyloidosis | Research

Needs of amyloidosis patients and their care providers: design & first results of the  AMY-NEEDS research and care program

Authors: Sandra Michaela Ihne-Schubert, Teresa Radovic, Saskia Fries, Stefan Frantz, Hermann Einsele, Stefan Störk, Silke Neuderth

Published in: Orphanet Journal of Rare Diseases | Issue 1/2024

Login to get access

Abstract

Background

Amyloidosis represents a rare yet heterogeneous multi-system disorder associated with a grave prognosis and an enormous psycho-emotional strain on patients, relatives, and caregivers. We here present the overall study design and first results of AMY-NEEDS, a research program aiming to systematically assess the needs of patients suffering from amyloidosis, their relatives and health care professionals (HCPs), and develop an amyloidosis-specific care approach.

Methods

AMY-NEEDS uses a mixed-methods approach including focus groups (step 1), a questionnaire-based broad evaluation within the local amyloidosis patient collective (step 2), and the development of a needs-adapted care concept (step 3).

Results

Seven patients, six relatives and five HCPs participated in the focus groups (step 1). At the time of diagnosis, patients expressed the need of a smooth diagnostic process, possibly enhanced through improved awareness and better education of local HCPs. There was a strong wish to receive well-founded information and comprehensive support including companionship during medical visits, experience the feeling of being understood, find trust in that “everything possible” is being done, and have effortless access to centre staff. In the course of the disease, patients favoured that the specialized centre should manage treatment coordination, monitoring and psychosocial support. The interface between centre and local HCPs was regarded of particular importance, requiring further investigation into its optimal design.

Conclusions

Patients with amyloidosis express particular needs that should appropriately be considered in specifically tailored care concepts.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ihne S, Morbach C, Sommer C, Geier A, Knop S, Störk S. Amyloidosis—the diagnosis and treatment of an underdiagnosed disease. Dtsch Arztebl Int. 2020;2020(117):159–66. Ihne S, Morbach C, Sommer C, Geier A, Knop S, Störk S. Amyloidosis—the diagnosis and treatment of an underdiagnosed disease. Dtsch Arztebl Int. 2020;2020(117):159–66.
2.
go back to reference Lousada I, Comenzo RL, Landau H, Guthrie S, Merlini G. Light chain amyloidosis: patient experience survey from the amyloidosis research consortium. Adv Ther. 2015;32(10):920–8.CrossRefPubMedPubMedCentral Lousada I, Comenzo RL, Landau H, Guthrie S, Merlini G. Light chain amyloidosis: patient experience survey from the amyloidosis research consortium. Adv Ther. 2015;32(10):920–8.CrossRefPubMedPubMedCentral
3.
go back to reference McCausland KL, White MK, Guthrie SD, Quock T, Finkel M, Lousada I, et al. Light chain (AL) amyloidosis: the journey to diagnosis. Patient. 2017. McCausland KL, White MK, Guthrie SD, Quock T, Finkel M, Lousada I, et al. Light chain (AL) amyloidosis: the journey to diagnosis. Patient. 2017.
4.
go back to reference Lane T, Fontana M, Martinez-Naharro A, Quarta CC, Whelan CJ, Petrie A, et al. Natural History, quality of life, and outcome in cardiac transthyretin amyloidosis. Circulation. 2019;140(1):16–26.CrossRefPubMed Lane T, Fontana M, Martinez-Naharro A, Quarta CC, Whelan CJ, Petrie A, et al. Natural History, quality of life, and outcome in cardiac transthyretin amyloidosis. Circulation. 2019;140(1):16–26.CrossRefPubMed
5.
go back to reference Sanchorawala V, McCausland KL, White MK, Bayliss MS, Guthrie SD, Lo S, et al. A longitudinal evaluation of health-related quality of life in patients with AL amyloidosis: associations with health outcomes over time. Br J Haematol. 2017;179(3):461–70.CrossRefPubMedPubMedCentral Sanchorawala V, McCausland KL, White MK, Bayliss MS, Guthrie SD, Lo S, et al. A longitudinal evaluation of health-related quality of life in patients with AL amyloidosis: associations with health outcomes over time. Br J Haematol. 2017;179(3):461–70.CrossRefPubMedPubMedCentral
6.
go back to reference Bayliss M, McCausland KL, Guthrie SD, White MK. The burden of amyloid light chain amyloidosis on health-related quality of life. Orphanet J Rare Dis. 2017;12(1):15.CrossRefPubMedPubMedCentral Bayliss M, McCausland KL, Guthrie SD, White MK. The burden of amyloid light chain amyloidosis on health-related quality of life. Orphanet J Rare Dis. 2017;12(1):15.CrossRefPubMedPubMedCentral
7.
go back to reference Drent G, Graveland CW, Hazenberg BP, Haagsma EB. Quality of life in patients with familial amyloidotic polyneuropathy long-term after liver transplantation. Amyloid. 2009;16(3):133–41.CrossRefPubMed Drent G, Graveland CW, Hazenberg BP, Haagsma EB. Quality of life in patients with familial amyloidotic polyneuropathy long-term after liver transplantation. Amyloid. 2009;16(3):133–41.CrossRefPubMed
8.
go back to reference Tausch AM, N. Methodische Aspekte der Durchführung von Fokusgruppen in der Gesundheitsforschung: Welche Anforderungen ergeben sich aufgrund der besonderen Zielgruppen und Fragestellungen? GESIS Papers. 2015. Tausch AM, N. Methodische Aspekte der Durchführung von Fokusgruppen in der Gesundheitsforschung: Welche Anforderungen ergeben sich aufgrund der besonderen Zielgruppen und Fragestellungen? GESIS Papers. 2015.
9.
go back to reference Schulz M. Quick and easy!? Fokusgruppen in der angewandten Sozialwissenschaft. In Schulz, M.; Mack, B. & Renn, O. (Eds.), Fokusgruppen in der empirischen Sozialwissenschaft. VS Verlag für Sozialwissenschaften, Springer Fachmedien Wiesbaden. 2012. Schulz M. Quick and easy!? Fokusgruppen in der angewandten Sozialwissenschaft. In Schulz, M.; Mack, B. & Renn, O. (Eds.), Fokusgruppen in der empirischen Sozialwissenschaft. VS Verlag für Sozialwissenschaften, Springer Fachmedien Wiesbaden. 2012.
10.
go back to reference Ruddat M. Auswertung von Fokusgruppen mittels Zusammenfassung zentraler Diskussionsaspekte. In: Schulz M, Mack B, Renn O, editors. Fokusgruppen in der empirischen Sozialwissenschaft - Von der Konzeption bis zur Auswertung. VS Verlag für Sozialwissenschaften; 2012. p. 195–206.CrossRef Ruddat M. Auswertung von Fokusgruppen mittels Zusammenfassung zentraler Diskussionsaspekte. In: Schulz M, Mack B, Renn O, editors. Fokusgruppen in der empirischen Sozialwissenschaft - Von der Konzeption bis zur Auswertung. VS Verlag für Sozialwissenschaften; 2012. p. 195–206.CrossRef
11.
go back to reference Hess V, Meng K, Schulte T, Neuderth S, Bengel J, Jentschke E, et al. Unexpressed psychosocial needs in cancer patients at the beginning of inpatient rehabilitation: a qualitative analysis. J Psychosoc Oncol. 2021;39(2):173–88.CrossRefPubMed Hess V, Meng K, Schulte T, Neuderth S, Bengel J, Jentschke E, et al. Unexpressed psychosocial needs in cancer patients at the beginning of inpatient rehabilitation: a qualitative analysis. J Psychosoc Oncol. 2021;39(2):173–88.CrossRefPubMed
12.
go back to reference Hess V, Meng K, Schulte T, Neuderth S, Bengel J, Faller H, et al. Prevalence and predictors of cancer patients’ unexpressed needs in the admission interview of inpatient rehabilitation. Psychooncology. 2020;29(10):1549–56.CrossRefPubMed Hess V, Meng K, Schulte T, Neuderth S, Bengel J, Faller H, et al. Prevalence and predictors of cancer patients’ unexpressed needs in the admission interview of inpatient rehabilitation. Psychooncology. 2020;29(10):1549–56.CrossRefPubMed
13.
go back to reference Seekatz B, Lukasczik M, Lohr M, Ehrmann K, Schuler M, Kessler AF, et al. Screening for symptom burden and supportive needs of patients with glioblastoma and brain metastases and their caregivers in relation to their use of specialized palliative care. Supp Care Cancer. 2017;25(9):2761–70.CrossRef Seekatz B, Lukasczik M, Lohr M, Ehrmann K, Schuler M, Kessler AF, et al. Screening for symptom burden and supportive needs of patients with glioblastoma and brain metastases and their caregivers in relation to their use of specialized palliative care. Supp Care Cancer. 2017;25(9):2761–70.CrossRef
14.
go back to reference Heß VMKS, T.; Neuderth, S.; Bengel, J.; Faller, H.; Schuler, M. . Decreased Mental Health, Quality of Life, and Utilization of Professional Help in Cancer Patients with Unexpressed Needs. A Longitudinal Analysis. . Journal of Psychosomatic Research. 2021 (under review). Heß VMKS, T.; Neuderth, S.; Bengel, J.; Faller, H.; Schuler, M. . Decreased Mental Health, Quality of Life, and Utilization of Professional Help in Cancer Patients with Unexpressed Needs. A Longitudinal Analysis. . Journal of Psychosomatic Research. 2021 (under review).
15.
go back to reference Guder G, Stork S, Gelbrich G, Brenner S, Deubner N, Morbach C, et al. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling. Eur J Heart Fail. 2015;17(4):442–52.CrossRefPubMed Guder G, Stork S, Gelbrich G, Brenner S, Deubner N, Morbach C, et al. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling. Eur J Heart Fail. 2015;17(4):442–52.CrossRefPubMed
16.
go back to reference Angermann CE, Stork S, Gelbrich G, Faller H, Jahns R, Frantz S, et al. Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study. Circ Heart Fail. 2012;5(1):25–35.CrossRefPubMed Angermann CE, Stork S, Gelbrich G, Faller H, Jahns R, Frantz S, et al. Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study. Circ Heart Fail. 2012;5(1):25–35.CrossRefPubMed
17.
go back to reference Stork S, Faller H, Schowalter M, Ertl G, Angermann CE. Evidence-based disease management in patients with heart failure (HeartNetCare-HF Wurzburg). Dtsch Med Wochenschr. 2009;134(15):773–6.PubMed Stork S, Faller H, Schowalter M, Ertl G, Angermann CE. Evidence-based disease management in patients with heart failure (HeartNetCare-HF Wurzburg). Dtsch Med Wochenschr. 2009;134(15):773–6.PubMed
18.
go back to reference Neuderth SST, Schowalter M, Richard M, Störk S, Angermann CE, Faller H. Schulungsbedürfnis Bei Patienten Mit Chronischer Herzinsuffizienz. Zeitschrift für Medizinische Psychologie. 2006;15(2):77–85. Neuderth SST, Schowalter M, Richard M, Störk S, Angermann CE, Faller H. Schulungsbedürfnis Bei Patienten Mit Chronischer Herzinsuffizienz. Zeitschrift für Medizinische Psychologie. 2006;15(2):77–85.
19.
go back to reference Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133(24):2404–12.CrossRefPubMed Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133(24):2404–12.CrossRefPubMed
20.
go back to reference Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018;379(11):1007–16.CrossRefPubMed Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018;379(11):1007–16.CrossRefPubMed
21.
go back to reference Harrison JD, Young JM, Price MA, Butow PN, Solomon MJ. What are the unmet supportive care needs of people with cancer? A systematic review. Supp Care Cancer. 2009;17(8):1117–28.CrossRef Harrison JD, Young JM, Price MA, Butow PN, Solomon MJ. What are the unmet supportive care needs of people with cancer? A systematic review. Supp Care Cancer. 2009;17(8):1117–28.CrossRef
22.
go back to reference Walsh J, Markus HS. Telemedicine for follow-up of rare neurological disease. Stroke. 2019;50(3):750–3.CrossRefPubMed Walsh J, Markus HS. Telemedicine for follow-up of rare neurological disease. Stroke. 2019;50(3):750–3.CrossRefPubMed
23.
go back to reference Watson N, Kurudzhu H, Green A, Summers D, Smith C, Pal S. Application of telehealth for comprehensive Creutzfeldt-Jakob disease surveillance in the United Kingdom. J Neurol Sci. 2021;420: 117221.CrossRefPubMed Watson N, Kurudzhu H, Green A, Summers D, Smith C, Pal S. Application of telehealth for comprehensive Creutzfeldt-Jakob disease surveillance in the United Kingdom. J Neurol Sci. 2021;420: 117221.CrossRefPubMed
24.
go back to reference Ammenwerth E, Modre-Osprian R, Fetz B, Gstrein S, Krestan S, Dorler J, et al. HerzMobil, an integrated and collaborative telemonitoring-based disease management program for patients with heart failure: a feasibility study paving the way to routine care. JMIR Cardio. 2018;2(1): e11.CrossRefPubMedPubMedCentral Ammenwerth E, Modre-Osprian R, Fetz B, Gstrein S, Krestan S, Dorler J, et al. HerzMobil, an integrated and collaborative telemonitoring-based disease management program for patients with heart failure: a feasibility study paving the way to routine care. JMIR Cardio. 2018;2(1): e11.CrossRefPubMedPubMedCentral
Metadata
Title
Needs of amyloidosis patients and their care providers: design & first results of the  AMY-NEEDS research and care program
Authors
Sandra Michaela Ihne-Schubert
Teresa Radovic
Saskia Fries
Stefan Frantz
Hermann Einsele
Stefan Störk
Silke Neuderth
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Amyloidosis
Published in
Orphanet Journal of Rare Diseases / Issue 1/2024
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-024-03052-w

Other articles of this Issue 1/2024

Orphanet Journal of Rare Diseases 1/2024 Go to the issue